The 96-week clinical outcomes after cessation of nucleos(t)ide analog treatment in chronic hepatitis B patients
{{output}}
Background: Chronic hepatitis B (CHB) patients have a high virological relapse rate after cessation of nucleos(t)ide analog (NA) treatment, but the clinical outcome remains unclear. This study aimed to investigate the 96-week cli... ...
